Manhattan Scientifics, Inc. (MHTX)
OTCMKTS
· Delayed Price · Currency is USD
0.0006
-0.0001 (-14.29%)
Dec 20, 2024, 4:00 PM EST
Manhattan Scientifics Statistics
Total Valuation
Manhattan Scientifics has a market cap or net worth of 335,569. The enterprise value is 1.42 million.
Market Cap | 335,569 |
Enterprise Value | 1.42M |
Important Dates
The next estimated earnings date is Thursday, April 3, 2025.
Earnings Date | Apr 3, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Manhattan Scientifics has 559.28 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 559.28M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 15.22% |
Owned by Institutions (%) | 0.12% |
Float | 474.16M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.34 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
Current Ratio | 0.02 |
Quick Ratio | 0.02 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -132.78% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -1.06M |
Employee Count | 1 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.09% in the last 52 weeks. The beta is 1.32, so Manhattan Scientifics's price volatility has been higher than the market average.
Beta (5Y) | 1.32 |
52-Week Price Change | -59.09% |
50-Day Moving Average | 0.00 |
200-Day Moving Average | 0.00 |
Relative Strength Index (RSI) | 42.36 |
Average Volume (20 Days) | 613,373 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.03 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -683,000 |
Pretax Income | -1.06M |
Net Income | -1.06M |
EBITDA | -682,500 |
EBIT | -683,000 |
Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 38,000 in cash and 60,000 in debt, giving a net cash position of -22,000 or -0.00 per share.
Cash & Cash Equivalents | 38,000 |
Total Debt | 60,000 |
Net Cash | -22,000 |
Net Cash Per Share | -0.00 |
Equity (Book Value) | -2.34M |
Book Value Per Share | -0.01 |
Working Capital | -2.37M |
Cash Flow
Operating Cash Flow | -110,000 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Manhattan Scientifics does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -314.67% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |